Literature DB >> 1995726

Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8.

B Christensson1, A Boutonnier, U Ryding, J M Fournier.   

Abstract

Consecutive serum samples from patients with Staphylococcus aureus endocarditis or septicemia or non-S. aureus endocarditis and febrile nonsepticemic controls were tested for antibodies against S. aureus capsular polysaccharide (CP) types 5 and 8 by ELISA. The upper normal antibody levels were defined as the upper 99.5% confidence limits of the values from the febrile controls. All available patient isolates were tested for the presence of CP type 5 or 8 (85% of the isolates expressed either serotype), and all five patients with S. aureus endocarditis had positive antibody levels against the corresponding serotype within the first 10 days of infection. Three other endocarditis patients lacked isolates for CP testing but two of these were positive. Positive antibody levels were found in 0 of 28 septicemia patients, in 1 of 12 non-S. aureus endocarditis patients, and in 3 of 37 febrile controls. Thus, testing for anti-CP 5 or 8 antibodies, especially together with CP serotyping of the patient's isolate, seems to provide important information in the differential diagnosis of endocarditis in patients with S. aureus septicemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995726     DOI: 10.1093/infdis/163.3.530

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Authors:  Patricia Colque-Navarro; Gunnar Jacobsson; Rune Andersson; Jan-Ingmar Flock; Roland Möllby
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

3.  Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.

Authors:  P Colque-Navarro; M Palma; B Söderquist; J I Flock; R Möllby
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 4.  Virulence factors among gram-positive bacteria in experimental endocarditis.

Authors:  L M Baddour
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Comparison of Capsular Typing of Staphylococcus aureus with Bacteriophage Typing: A Study in Gulbarga, India.

Authors:  Maneesh Paul-Satyaseela; Channappa T Shivannavar; Subhashchandra M Gaddad
Journal:  Indian J Microbiol       Date:  2011-02-14       Impact factor: 2.461

6.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 7.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.

Authors:  M Thakker; J S Park; V Carey; J C Lee
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Authors:  J Nemeth; J C Lee
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.